Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Thuy Trang Nguyen | - |
dc.contributor.author | Tuong Kha Vo | - |
dc.contributor.author | Vo, Giau Van | - |
dc.date.accessioned | 2021-05-24T05:40:12Z | - |
dc.date.available | 2021-05-24T05:40:12Z | - |
dc.date.created | 2021-03-29 | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 0065-2598 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/81076 | - |
dc.description.abstract | Alzheimer’s disease (AD) is a neurodegenerative disorder in which the death of brain cells causes memory loss and cognitive decline. Existing drugs only suppress symptoms or delay further deterioration but do not address the cause of the disease. In spite of screening numerous drug candidates against various molecular targets of AD, only a few candidates, such as acetylcholinesterase inhibitors, are currently utilized as an effective clinical therapy. Currently, nano-based therapies can make a difference, providing new therapeutic options by helping drugs to cross the blood-brain barrier and enter the brain more effectively. The main aim of this review was to highlight advances in research on the development of nano-based therapeutics for improved treatment of AD. © 2021, The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER INTERNATIONAL PUBLISHING AG | - |
dc.relation.isPartOf | REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II | - |
dc.title | Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000637940600014 | - |
dc.identifier.doi | 10.1007/978-3-030-55035-6_13 | - |
dc.identifier.bibliographicCitation | REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II, v.1286, pp.183 - 198 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85102894042 | - |
dc.citation.endPage | 198 | - |
dc.citation.startPage | 183 | - |
dc.citation.title | REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II | - |
dc.citation.volume | 1286 | - |
dc.contributor.affiliatedAuthor | Vo, Giau Van | - |
dc.type.docType | Book Chapter | - |
dc.subject.keywordAuthor | Alzheimer’s disease | - |
dc.subject.keywordAuthor | CNS | - |
dc.subject.keywordAuthor | Molecular targets | - |
dc.subject.keywordAuthor | Nanotherapeutic | - |
dc.subject.keywordAuthor | Oxidative stress | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.